Increased consumption of processed foods, larger portion sizes, and lower physical activity contribute to America's obesity problem.
GLP-1s have helped stabilize the growth of obesity, but women experience more side effects than men when prescribed these drugs.
Olio Labs leverages AI and computational biology to design combination therapeutics for obesity and aims to address the gender differences in drug reactions.
Advances in technology and science offer potential solutions to personalized medicine, improved symptom control, and reduced dosing in the future of health.